Go to deals
Private Equity | Healthcare

Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital

Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.

Ace Pharmaceuticals is a leading pharmaceutical company in the niche of medical need products, and is based in Zeewolde, the Netherlands. As an independent company, Ace focuses on the development, production and distribution of licensed and unlicensed medicines. With its activities, Ace meets an essential social need: making and keeping scarce medication available for people for whom it is essential. It does so by actively collaborating with relevant stakeholders, including patient associations, doctors and governmental institutions. Since January 2020, Ace has also been supplying pharmaceutical compounding products to pharmacies in the Netherlands through its business unit Ace Compounding.

Oaklins’ debt advisory team in the Netherlands acted as advisor to the consortium and assisted in establishing a financing package aligned with the current business profile and future growth ambitions.

Service
Funding, debt advisory & ECM
Parties
“The COVID-19 pandemic has clearly highlighted the challenges and gaps in our industry in Europe. It makes our mission to make scarce medicines available more important than ever. We want to respond to this situation strongly by growing organically as well as through acquisitions in Europe. With the capital, the know-how and the broad (international) network of Gilde Buy Out Partners, Gilde Healthcare, and our existing investor Quadrum Capital, we can achieve this in both a socially responsible as well as financially sound manner.”

Jan Willem Popma

Director, Ace Pharmaceuticals BV

Talk to the deal team

 Bas  Stoetzer

Bas Stoetzer

Partner

Amsterdam, Netherlands
Oaklins Netherlands
 Jeroen  Derkx

Jeroen Derkx

Director

Amsterdam, Netherlands
Oaklins Netherlands
 Niels  Vermuë

Niels Vermuë

Associate

Amsterdam, Netherlands
Oaklins Netherlands

Related deals

BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher
Private Equity | Other Industries

BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher

BaltCap Lithuania SME Fund has sold its 46% shareholding in Labochema UAB, a Lithuanian laboratory supplies trading company, to Dominique Dutscher. Labochema’s CEO and the chairman also sold their shareholdings. As a result of the transaction, Dominique Dutscher now controls 100% of Labochema.

Learn more
VækstPartner Kapital and founders and management sell CIM Industrial Systems to XANO
Private Equity | TMT

VækstPartner Kapital and founders and management sell CIM Industrial Systems to XANO

VækstPartner Kapital and the founders and management of the leading pharma/industry 4.0 production software specialist CIM Industrial Systems A/S have sold the company to the listed Swedish group XANO Industri AB.

Learn more
Paaschburg & Wunderlich GmbH has been acquired by Bihr N.V.
Private Equity | Consumer & Retail

Paaschburg & Wunderlich GmbH has been acquired by Bihr N.V.

The shareholders of Paaschburg & Wunderlich GmbH (P&W) have sold 100% of their shares to Bihr N.V.

Learn more